 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AUSTIN, TX & DURHAM, NC, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference

Shattuck Labs, Inc. (STTK) Q3 2023 Earnings Call Transcript...

Shattuck Labs, Inc. (STTK) Q3 2023 Earnings Call Transcript

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Shattuck Labs reports Q3 EPS (65c), consensus (52c)

Recap: Shattuck Labs Q3 Earnings

Positive interim data from Phase 1B clinical trial of SL-172154 in combination with pegylated liposomal doxorubicin (PLD) in platinum-resistant ovarian cancer (PROC) demonstrated an acceptable safety...

Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Shattuck Labs, Inc. 2023 Q3 - Results - Earnings Call Presentation...

Shattuck Labs, Inc. 2023 Q3 - Results - Earnings Call Presentation

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Shattuck Labs (STTK Research Report), with a price t...

Shattuck Labs Earns Buy Rating: Promising Trial Results and Solid Financial Health

Key Clinical Progress and Financial Metrics RevealedRelated Stocks: STTK...

Shattuck Labs Inc (STTK) Reports Q3 2023 Financial Results and Business Updates

Shattuck Labs, Inc. (NASDAQ:STTK  Get Free Report) was up 14.1% on Monday . The stock traded as high as $2.20 and last traded at $2.11. Approximately 79,933 shares were traded during trading...

Shattuck Labs (NASDAQ:STTK) Trading Up 14.1%

AUSTIN, TX andDURHAM, NC, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Watchers	196
52-Wk Low	$1.33
52-Wk High	$4.77

Market Cap	$97.29M
Volume (M)	6,153.00
52-Wk High	$4.77
52-Wk Low	$1.33

STTK Shattuck Labs Inc

About

Feed

News

Sentiment

Earnings

Fundamentals